drugset / Trial / NCT04826237
Oral Statins and Protection From Hearing Loss
RandomizedParallel-groupTriple-blindTreatment
Summary
A small clinical trial for idiopathic sudden sensorineural hearing loss (ISSNHL). Will the addition of an oral statin to the standard treatment (oral methylprednesolone and the salvage therapy of intratympanic dexamethasone) improve the treatment outcome for patients with ISSNHL? This study will compare the two treatments and quantitatively evaluate hearing and speech discrimination and have the patients subjectively evaluate tinnitus.
Timeline
- Start
- 2023-02-09
- Primary completion
- 2025-10-01
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Dexamethasone | Small molecule | — | — |
| Background | Methylprednisolone | Other / unclassified | 16 mg | Oral |